Galectin-3-994
Test info
Galectin-3
994
LAB994
MSO
For use in conjunction with clinical evaluation as an aid in assessing the prognosis of patients with chronic heart failure.
Specimen
Serum
0.8 mL
0.4 mL
Immediately following collection, thoroughly mix sample by gently inverting 5 times
- Allow sample to clot for a minimum of 30 minutes
- Spin within two (2) hours of sample collection
Gold serum separator (SST) tube
EDTA plasma
Lavender:
Immediately following collection, mix sample thoroughly by gentle inverting 8 - 10 times to prevent clotting
Red:
- Allow sample to clot
- Spin within two (2) hours of sample collection
- Transfer serum to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as serum
Lavender:
- Spin within two (2) hours of sample collection
- Transfer plasma to a Transfer vial/tube with cap - 12mL (LabCorp), labelled as EDTA plasma
Ambient (preferred) - 22 days
Refrigerated - 22 days
Frozen - 12 months
Freeze/thaw cycles - stable x9
- Visible hemolysis
- Plasma other than EDTA
Performance
LabCorp Burlington (004110): R-NX
Tu, Th
7 days
Enzyme Immunoassay (EIA)
Clinical and Interpretive info
< 22.2 ng/mL
Galectin-3 levels > 17.8 ng/mL are present in a proportion of patients with NYHA class II-IV. Such elevated levels are associated with a more progressive form of heart failure resulting in an increased hazard for death or hospitalization.
Billing
82777
Result 62419-7
Tracking
05/29/2019
03/16/2022
12/22/2023